SERB PHARMACEUTICALS

HQ - Brussels

Summary

SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care and rare diseases.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 368 M

Avg. Deal Size£ 184 M

Market Context

Senior Management